Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Badley and Zelalem Temesgen.
Connection Strength
2.110
-
In Reply - Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019. Mayo Clin Proc. 2021 03; 96(3):817-818.
Score: 0.923
-
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 11; 95(11):2382-2394.
Score: 0.901
-
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
Score: 0.230
-
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 07 07; 9.
Score: 0.056